Status:

COMPLETED

Feasibility and Safety of an Ileus Management Protocol for Postoperative Ileus After Abdominal Surgery

Lead Sponsor:

University of Lausanne Hospitals

Conditions:

Ileus Postoperative

Nasogastric Tube

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this clinical trial is to evaluate whether a standardized treatment algorithm, the Ileus Management Protocol (I-MAP), is feasible and safe for the management of patients who develop postop...

Eligibility Criteria

Inclusion

  • Adults ≥18 years of age.
  • Patients who undergo abdominal surgery and develop postoperative ileus (POI) within 30 days.
  • Provided general consent for participation.

Exclusion

  • Preoperative bowel obstruction.
  • Anastomotic leak.
  • Prophylactic nasogastric tube (NGT) placement.
  • Pregnancy.
  • Lack of general consent.

Key Trial Info

Start Date :

May 31 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2024

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT07194525

Start Date

May 31 2023

End Date

April 1 2024

Last Update

September 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre hospitalier universitaire vaudois (CHUV)

Lausanne, Canton of Vaud, Switzerland, 1005

Feasibility and Safety of an Ileus Management Protocol for Postoperative Ileus After Abdominal Surgery | DecenTrialz